Together, these results presented evidence of impaired CD4+ and CD8+ T cell surveillance directed against EBV in HIV-positive individuals, with exacerbated immune defects observed in advanced HIV disease and HIV-positive patients with EBV-associated lymphoma. The gene discussed is CD8A; the disease is lymphoma.